Molecular Bases of Disease and Drug Design
Molecular Bases of Disease and Drug Design

Production

MOLBD3 facility offers advanced protein expression services across multiple expression systems, including E. coli, insect cells, mammalian cells and yeast to meet a wide range of research and industrial requirements.
Each expression system is carefully evaluated and optimized in terms of scalability, protein yield, solubility and post-translational modification capabilities, ensuring the most effective solution for each project and purpose.

The selection of the appropriate expression platform is guided by the final application of the protein, whether for structural and functional studies, assay development or therapeutic and industrial production. This tailored approach guarantees high-quality proteins and optimal performance, supporting both exploratory research and translational development.